Synthesis and characterization of novel copolymeric resveratrol conjugates

Journal of Chemistry

Volumn 2015, Issue , 2015, Pages

  Ng, Yan Jing ^a   Benson, Heather A E ^a   Brown, David H ^a   Chen, Yan ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928400786     PISSN: 20909063     EISSN: 20909071     Source Type: Journal    
DOI: 10.1155/2015/245625     Document Type: Article

References (28)

1. Y. Bai, Q.-Q. Mao, J. Qin et al. , "Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo," Cancer Science, vol. 101, no. 2, pp. 488-493, 2010.
2. P. W. Mannal, J. A. Alosi, J. G. Schneider, D. E. McDonald, and D. W. McFadden, "Pterostilbene inhibits pancreatic cancer in vitro," Journal of Gastrointestinal Surgery, vol. 14, no. 5, pp. 873-879, 2010.
3. Y. Bai, Q.-Q. Mao, J. Qin et al. , "Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo," Cancer Science, vol. 101, no. 2, pp. 488-493, 2010.
4. J.-N. Lin, V. C.-H. Lin, K.-M. Rau et al. , "Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation," Journal of Agricultural and Food Chemistry, vol. 58, no. 3, pp. 1584-1592, 2010.
5. L. Fremont, "Minireview: biological effects of resveratrol," Life Sciences, vol. 66, no. 8, pp. 663-673, 2000.
6. J. A. Baur and D. A. Sinclair, "Therapeutic potential of resveratrol: the in vivo evidence," Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 493-506, 2006.
7. G. Singh and R. S. Pai, "Recent advances of resveratrol in nanostructured based delivery systems and in themanagement of HIV/AIDS," Journal of Controlled Release, vol. 194, pp. 178-188, 2014.
8. T. Walle, F. Hsieh,M. H. DeLegge, J. E. Oatis Jr. , and U. K. Walle, "High absorption but very low bioavailability of oral resveratrol in humans,"DrugMetabolismandDisposition, vol. 32,no. 12,pp. 1377-1382, 2004.
9. C. Yu, Y. Geun Shin, A. Chow et al. , "Human, rat, and mouse metabolism of resveratrol," Pharmaceutical Research, vol. 19, no. 12, pp. 1907-1914, 2002.
10. M. Belleri, D. Ribatti, M. Savio et al. , " αvβ3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers," Molecular CancerTherapeutics, vol. 7, no. 12, pp. 3761-3770, 2008.
11. H. J. Lee, J. W. Seo, B. H. Lee, K.-H. Chung, and D. Y. Chi, "Syntheses and radical scavenging activities of resveratrol derivatives," Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 2, pp. 463-466, 2004.
12. L.-X. Wang, A. Heredia, H. Song et al. , "Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity," Journal of Pharmaceutical Sciences, vol. 93, no. 10, pp. 2448-2457, 2004.
13. K. Teskac and J. Kristl, "The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol," International Journal of Pharmaceutics, vol. 390, no. 1, pp. 61-69, 2010.
14. N. K. Narayanan, D. Nargi, C. Randolph, and B. A. Narayanan, "Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice," International Journal of Cancer, vol. 125, no. 1, pp. 1-8, 2009.
15. J. Lu, S. C. Owen, and M. S. Shoichet, "Stabilityof self-assembled polymeric micelles in serum," Macromolecules, vol. 44, no. 15, pp. 6002-6008, 2011.
16. S. Das, H.-S. Lin, P. C. Ho, and K.-Y. Ng, "The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol," Pharmaceutical Research, vol. 25, no. 11, pp. 2593-2600, 2008.
17. M. Sessa, R. Tsao, R. Liu, G. Ferrari, and F. Donsi, "Evaluation of the stability and antioxidant activity of nanoencapsulated resveratrol during in vitro digestion," Journal of Agricultural and Food Chemistry, vol. 59, no. 23, pp. 12352-12360, 2011.
18. J. Shao, X. Li, X. Lu et al. , "Enhanced growth inhibition effect of Resveratrol incorporated into biodegradable nanoparticles against glioma cells ismediated by the induction of intracellular reactive oxygen species levels," Colloids and Surfaces B: Biointerfaces, vol. 72, no. 1, pp. 40-47, 2009.
19. W. Guo, A. Li, Z. Jia, Y. Yuan, H. Dai, and H. Li, "Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma," European Journal of Pharmacology, vol. 718, no. 1-3, pp. 41-47, 2013.
20. L. Bu, L.-C. Gan, X.-Q. Guo et al. , "Trans-resveratrol loaded chitosan nanoparticlesmodifiedwith biotin and avidin to target hepatic carcinoma," International Journal of Pharmaceutics, vol. 452, no. 1-2, pp. 355-362, 2013.
21. Y. Li, S. Dnmark, U. Edlund et al. , "Resveratrol-conjugated poly-caprolactone facilitates in vitro mineralization and in vivo bone regeneration," Acta Biomaterialia, vol. 7, no. 2, pp. 751-758, 2011.
22. D. Kumar, K. K. Raj, S. V. Malhotra, and D. S. Rawat, "Synthesis and anticancer activity evaluation of resveratrol-chalcone conjugates," MedChemComm, vol. 5, no. 4, pp. 528-535, 2014.
23. A. Mattarei, M. Carraro, M. Azzolini, C. Paradisi, M. Zoratti, and L. Biasutto, "New water-soluble carbamate ester derivatives of resveratrol," Molecules, vol. 19, no. 10, pp. 15900-15917, 2014.
24. H. Tang, C. J. Murphy, B. Zhang et al. , "Curcumin polymers as anticancer conjugates," Biomaterials, vol. 31, no. 27, pp. 7139-7149, 2010.
25. B. Siddalingappa, H. A. E. Benson, D. H. Brown, K. T. Batty, and Y. Chen, "Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profile," PLoS ONE. In press.
26. V. F. Tamboli, An electrospray ionization mass spectrometric study on reactivity of resveratrol induced by metal ions [Ph. D. thesis], Department of Physics, University of Trento, Trento, Italy, 2012.
27. S. M. Loverde, M. L. Klein, and D. E. Discher, "Nanoparticle shape improves delivery: rational coarse grain molecular dynamics (rCG-MD) of taxol in worm-like PEG-PCL micelles," Advanced Materials, vol. 24, no. 28, pp. 3823-3830, 2012.
28. F. G. Bahar, K. Ohura, T. Ogihara, and T. Imai, "Species difference of esterase expression and hydrolase activity in plasma," Journal of Pharmaceutical Sciences, vol. 101, no. 10, pp. 3979-3988, 2012.